David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Kohl's
KSS
$2.08B
| $457K | ﹤0.01% |
10,000
| – | – |
|
2927
Prothena Corp
PRTA
$482M
| $456K | ﹤0.01% |
7,042
-797
| -10% | -$48.8K |
|
2928
VirnetX Holding Corp
VHC
$52.1M
| $455K | ﹤0.01% |
5,830
-420
| -7% | -$33K |
|
2929
AnaptysBio
ANAB
$1.73B
| $450K | ﹤0.01% |
+12,882
| New | +$347K |
|
|
NOAH
2930
Noah Holdings
NOAH
$597M
| $449K | ﹤0.01% |
+13,986
| New | +$427K |
|
|
AMTD
2931
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
| $449K | ﹤0.01% |
9,200
+1,300
| +16% | +$58.3K |
|
2932
BlackLine
BL
$1.86B
| $448K | ﹤0.01% |
13,141
-4,417
| -25% | -$149K |
|
2933
First Busey Corp
BUSE
$2.5B
| $446K | ﹤0.01% |
14,219
-10,282
| -42% | -$301K |
|
2934
Pathward Financial
CASH
$1.72B
| $446K | ﹤0.01% |
17,064
-11,223
| -40% | -$290K |
|
|
NEWS
2935
DELISTED
NewStar Financial, Inc.
NEWS
| $445K | ﹤0.01% |
37,923
-15,318
| -29% | -$167K |
|
|
CPN
2936
PUT
DELISTED
Calpine Corporation
CPN
| $443K | ﹤0.01% |
30,000
| – | – |
|
2937
Cass Information Systems
CASS
$735M
| $442K | ﹤0.01% |
9,206
+4,544
| +97% | +$217K |
|
|
VSI
2938
DELISTED
Vitamin Shoppe Inc.
VSI
| $442K | ﹤0.01% |
82,630
+68,714
| +494% | +$531K |
|
2939
PUT
G-III Apparel Group
GIII
$1.43B
| $441K | ﹤0.01% |
15,200
-17,700
| -54% | -$467K |
|
|
FCRD
2940
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $441K | ﹤0.01% |
47,279
+14,936
| +46% | +$144K |
|
2941
IAMGOLD
IAG
$12.4B
| $440K | ﹤0.01% |
71,939
-269,997
| -79% | -$1.57M |
|
2942
CALL
Aon
AON
$76.2B
| $438K | ﹤0.01% |
+3,000
| New | +$419K |
|
|
DMTX
2943
DELISTED
Dimension Therapeutics, Inc
DMTX
| $438K | ﹤0.01% |
+72,978
| New | +$189K |
|
2944
Clear Channel Outdoor Holdings
CCO
$1.2B
| $437K | ﹤0.01% |
94,054
-14,294
| -13% | -$62.6K |
|
|
DF
2945
PUT
DELISTED
Dean Foods Company
DF
| $435K | ﹤0.01% |
+40,000
| New | +$515K |
|
2946
CALL
Aptiv
APTV
$9.83B
| $433K | ﹤0.01% |
+4,400
| New | +$415K |
|
2947
Forrester Research
FORR
$228M
| $433K | ﹤0.01% |
10,341
+4,330
| +72% | +$174K |
|
|
ACC
2948
DELISTED
American Campus Communities, Inc.
ACC
| $431K | ﹤0.01% |
9,756
+1,334
| +16% | +$63.1K |
|
2949
Box
BOX
$4.64B
| $429K | ﹤0.01% |
22,192
-238,775
| -91% | -$4.49M |
|
|
SQBG
2950
DELISTED
Sequential Brands Group, Inc.
SQBG
| $429K | ﹤0.01% |
3,588
+589
| +20% | +$70.6K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.